Bixiye
QP42-17 Professional Providers FAQ for Restricted Recipient Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 04, 2017
Natiijooyinka Raadinta
Soo bandhiga 2991 - 3000 ee natiijooyinka 3688
Bixiye
QP18-17 Reminder Regarding PCA Assessment Requests
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2017
Bixiye
QP5-17 Pharmacy Benefit Update - EpiPen, EpiPen Jr., Auvi-Q and Procysbi
Taariikhda uu dhaqangalayo Barnaamijka: Mar 06, 2017
Bixiye
QP55-18 New Drug - Epidiolex (cannabidiol) will Require Prior Authorization
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
QP27-18 Post Service Claim Appeals
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 24, 2018
Bixiye
QP87-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Lucemyra
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2018
Bixiye
QP47-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Opioids Extended Release
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2018
Bixiye
QP16-18 Pharmacy Benefit Update - Endari Exclusion
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2018
Bixiye
QP45-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Xermelo (telotristat)
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP21-16 Precription Drug - Electronic Prior Authorization (EPA) Drug Requests
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016